Turbine and AstraZeneca Team Up to Improve Cancer Treatments
Turbine and AstraZeneca have joined forces to make better cancer treatments using special medicines called antibody-drug conjugates (ADCs). Turbine has […]
New Hope for Early Alzheimer’s Treatment: ACI-35.030 Shows Promise
AC Immune SA has shared exciting news from their tests of two new treatments for early Alzheimer’s disease. These treatments,
Experts Urge More Investment in Alzheimer’s Diagnosis in Europe
Eli Lilly and top Alzheimer’s disease experts are asking for more investment in tools and resources to diagnose Alzheimer’s across
Important Updates from Medicare, FDA, and Biotech Companies
Today, we have some important news from Medicare, the Food and Drug Administration (FDA), and updates from several biotech companies
Big Pharma Company Buys Smaller One for $1.5 Billion to Expand Treatments
A large drug company, Bristol Myers Squibb (BMS), has decided to buy a smaller company called Orbital Therapeutics for $1.5
Pharmaceutical News
New Reporter Joins Our Health News Team
We’re pleased to welcome Annabel Kartal-Allen to our team. She writes for our health and medicine news sites. Annabel is
Takeda to Stop Research on Cell Therapy, Shift Focus to Other Treatments
Takeda, a big Japanese drug company, has decided to stop its research on cell therapy. This is a type of
Sheffield Hospital Leads Groundbreaking Study for Rare Autoimmune Disease
Sheffield Teaching Hospitals is the only UK location chosen for an important international research study that could change the way
Rocket Pharmaceuticals Stops Development of Gene Therapy for Rare Blood Disorder
Rocket Pharmaceuticals has decided to stop developing a gene therapy treatment for a rare blood disorder called Fanconi anaemia. This
Understanding Drug Development and the Role of Investors
Creating new medicines is a costly and uncertain process. Startup biotechnology companies often take many years before they can make